MedTrace Logo

Immersive Virtual Reality Meditation in Voice Therapy

NCT07176013 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-02-04

No results posted yet for this study

Summary

This study aims to explore the feasibility of incorporating regular guided meditations via immersive virtual reality (IVR) at the start of voice therapy sessions to facilitate better learning and retention of treatment. The study will involve 30 participants, and use the TRIPP application with the Meta Quest 2 virtual reality headset, known for its immersive meditation experiences designed to calm or focus the user. The objective is to investigate the immediate effects of meditation/mindfulness in IVR on vocal production, with the goal of improving self-regulation, attentional focus, and reducing vocal hyperfunction. IVR has been utilized in mental health settings and exposure therapy for various conditions, but its application in voice therapy, particularly for anxiety reduction through fully immersive meditation, remains unexplored. The study seeks to determine whether IVR can enhance therapy outcomes by improving engagement, attention, and vocal control in individuals undergoing voice therapy, potentially maximizing treatment gains. Through this research, the aim is to assess the efficacy of IVR in enhancing voice therapy interventions and addressing the unique challenges posed by stress and anxiety in voice users.

Conditions

  • Voice Disorders

Interventions

BEHAVIORAL

Voice therapy

All patients will receive a course of voice therapy as normal.

BEHAVIORAL

Meditation

Meditation at the start of each session. (each session is 30 minutes)

DEVICE

Virtual Reality

TRIPP application in the Meta Quest 2 Virtual Reality Headset.

Sponsors & Collaborators

Principal Investigators

  • Bradley R Hoff, MA, CCC-SLP · Icahn School of Medicine at Mount Sinai, Department of Otolaryngology

  • Ümit Daşdöğen, Ph.D., CCC-SLP · Icahn School of Medicine at Mount Sinai, Department of Otolaryngology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-03
Primary Completion
2026-09-30
Completion
2026-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07176013 on ClinicalTrials.gov